2Makita Z, Radoff S, Rayfield EJ, et al. Advanced glycosylation endproducts in patients with diabetic nephropathy N Eng. Med, 1991,325:836-842.
3Vlassara H. Protein glycation in the kidney:role in diabetes and aging. Kidney Int, 1996,49 : 1795 , 1840.
4Ono Y, Aoki S, Ohnishi K, et al. Increased serum levels of advanced glycation end products in NIDDM patients with diabetic complica-tions. Diabetes Care, 1998, 21: 1021-1027.
5Sima A, Sugimoto K. Experimental diabetic neuropathy: an update. Diabetologia, 1999, 42: 773-788.
6Kiuchi K, Nejima J, Takano T, et al. Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart, 2001, 85 : 87 -91.
7Vlassara H. Recent progress in advanced glycation end products and diabetic complications. Diabetes, 1997, 46 ( suppl 2) : s19-s25.
8Vlassara H.Protein glycation in the kidney:role in diabetes and aging[J].Kidney Int,1996,49:1795-1840.
9Vlassara H.Recent progress in advanced glycation end products and diabetic complications[J].Diabetes,1997,46 suppl 2:s19-s25.
10Nakamura S,Makita Z,Ishikawa S,et al.Progression of mephropathy in spontaneous diabetic rats is prevented by OPB-9195[J].Diabetes,1997,46:895-899.
